Cardiogenic Shock Remains Higher in Comorbid ACS, Diabetes
Patients with acute coronary syndrome and diabetes have significantly higher rates of cardiogenic shock and lower rates of revascularization.
Myocardial Infarction
Complete Revascularization Further Reduces CV Risk in STEMI
Investigators sought to determine whether PCI of nonculprit lesions further reduces risk for cardiovascular death or myocardial infarction in patients with STEMI.
Access Site Complication Rate Unchanged Despite Increase in Transradial PCI Use
Investigators examined the relationship between trends in primary and secondary vascular access sites and vascular access site complications among a cohort of patients who underwent PCI.
Complete Revascularization Best for STEMI With Multivessel CAD
For patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease, complete revascularization is superior to culprit lesion-only percutaneous coronary intervention.
Biodegradable Polymer Sirolimus-Eluting Stents May Be Superior for STEMI
For patients with STEMI undergoing primary PCI, there were fewer target lesion failures at one year in those receiving biodegradable polymer sirolimus-eluting stents.
Anemia Associated With Higher Mortality Rates in Acute Coronary Syndrome
Investigators evaluated the relationship among baseline anemia and ischemic events, bleeding events, and mortality in patients treated primarily with P2Y12 inhibitors during percutaneous coronary intervention for acute coronary syndrome.
No Difference in Device End Points for Biodegradable vs Durable Everolimus Polymer Stents
Investigators evaluated the efficacy and safety of a thin-strut, biodegradable-polymer everolimus-eluting stent and a thin-strut, durable-polymer everolimus-eluting stent.
Platelet Reactivity Not Predictive of MACE After Ticagrelor Loading During PCI
Investigators assessed the association between on-ticagrelor platelet reactivity and thrombotic events in patients with ACS treated by percutaneous coronary intervention.
Ischemic Postconditioning Reduced Mortality in STEMI Not Treated With Thrombectomy
These results suggest that ischemic postconditioning may have important therapeutic potential for STEMI not treated with thrombectomy.
What Is Driving Variations in High-Intensity Statin Use After MI?
Investigators examined the use of high-intensity statins after myocardial infarction in various hospital and regional settings.
